SecSonar.com

Arcadia Biosciences, Inc. (RKDA)

Arcadia Biosciences, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Arcadia Biosciences, Inc. (RKDA) is a Agricultural Inputs company based in US with a market capitalization of $1.5M. Revenue declined 3.7% year-over-year and free cash flow was negative at -$4.7M. This page tracks RKDA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 9 employees · IPO May 15, 2015

Valuation

Valuation & price

$0.96 · as of May 17, 2026 · -82.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.37

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$5.19$2.94$0.69Jul 25Dec 25Jun 26Jul 7, 25$4.67Jul 9, 25$4.65Jul 11, 25$4.78Jul 15, 25$4.74Jul 17, 25$4.54Jul 21, 25$4.54Jul 23, 25$4.37Jul 25, 25$4.28Jul 29, 25$4.10Jul 31, 25$4.30Aug 4, 25$4.34Aug 6, 25$4.60Aug 8, 25$4.63Aug 12, 25$4.45Aug 14, 25$4.41Aug 18, 25$4.47Aug 20, 25$4.38Aug 22, 25$4.09Aug 27, 25$3.84Aug 29, 25$3.86Sep 3, 25$3.12Sep 5, 25$3.15Sep 9, 25$3.18Sep 11, 25$3.48Sep 15, 25$3.46Sep 17, 25$3.51Sep 19, 25$3.62Sep 23, 25$3.78Sep 25, 25$3.51Sep 29, 25$3.44Oct 1, 25$3.47Oct 3, 25$3.47Oct 7, 25$3.38Oct 9, 25$4.08Oct 13, 25$3.34Oct 16, 25$5.19Oct 20, 25$4.92Oct 22, 25$3.89Oct 24, 25$4.10Oct 28, 25$3.78Oct 30, 25$3.71Nov 3, 25$3.61Nov 5, 25$3.72Nov 7, 25$3.69Nov 11, 25$3.66Nov 13, 25$3.86Nov 17, 25$3.73Nov 19, 25$3.60Nov 21, 25$3.66Nov 25, 25$3.58Nov 28, 25$3.59Dec 2, 25$3.67Dec 5, 25$3.64Dec 9, 25$3.81Dec 11, 25$3.70Dec 15, 25$3.67Dec 17, 25$3.80Dec 19, 25$3.69Dec 23, 25$3.21Dec 26, 25$2.60Dec 30, 25$1.82Jan 2, 26$2.15Jan 6, 26$2.13Jan 8, 26$2.75Jan 12, 26$2.43Jan 14, 26$2.26Jan 16, 26$2.40Jan 21, 26$2.26Jan 23, 26$2.26Jan 28, 26$2.18Jan 30, 26$2.05Feb 3, 26$1.97Feb 5, 26$1.76Feb 9, 26$1.83Feb 11, 26$1.72Feb 13, 26$1.68Feb 18, 26$1.78Feb 20, 26$1.89Feb 24, 26$1.87Feb 26, 26$1.97Mar 2, 26$1.96Mar 4, 26$1.85Mar 6, 26$1.97Mar 10, 26$2.04Mar 12, 26$1.92Mar 16, 26$1.76Mar 19, 26$1.65Mar 23, 26$1.70Mar 25, 26$1.70Mar 27, 26$1.47Mar 31, 26$1.38Apr 2, 26$1.35Apr 7, 26$1.31Apr 9, 26$1.34Apr 13, 26$1.33Apr 15, 26$1.39Apr 17, 26$1.18Apr 21, 26$1.12Apr 23, 26$1.06Apr 27, 26$1.08Apr 29, 26$1.06May 1, 26$1.12May 5, 26$1.15May 8, 26$1.07May 12, 26$1.06May 14, 26$1.07May 18, 26$0.94May 20, 26$0.95May 22, 26$0.92May 27, 26$0.93May 29, 26$0.96Jun 2, 26$1.01Jun 4, 26$1.03Jun 8, 26$0.92Jun 10, 26$0.90Jun 12, 26$1.03Jun 16, 26$0.85Jun 18, 26$0.78Jun 23, 26$0.72Jun 29, 26$0.69
$0.6752-week range$5.48
Loading valuation history…

Fundamentals

Key fundamentals

$1.5M

Market cap

-3.7%

Revenue growth (YoY)

36.2%

Gross margin

-$4.7M

Free cash flow (USD)

-$4.6M

Net debt

Net cash position

0.3%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Basic Materials

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$3.2MFY 2017$4.0MFY 2018$1.5MFY 2019$1.2MFY 2020$8.0MFY 2021$6.8MFY 2022$7.4MFY 2023$4.5MFY 2024$5.0MFY 2025$4.9M
$3.2M$4.9M

Free cash flow by year

2016 → 2025

FY 2016$-17.3MFY 2017$-14.0MFY 2018$-13.9MFY 2019$-18.7MFY 2020$-32.6MFY 2021$-26.9MFY 2022$-14.0MFY 2023$-15.3MFY 2024$-9.6MFY 2025$-4.7M
-$17.3M-$4.7M

Gross margin by year

2021 → 2025

FY 2021-28.4%FY 202217.8%FY 202351.2%FY 202441.3%FY 202536.2%
-28.4%36.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $-2.11)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventBonus Payment ApprovedJul 2, 2026Filing
  • FinancingSecurities RegistrationJun 26, 2026Filing
  • 8-K eventSecurities Purchase AgreementJun 15, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • Annual report10-K FiledApr 30, 2026Filing
  • 8-K eventAuditor ChangeApr 3, 2026Filing

Questions

Frequently asked questions

What is Arcadia Biosciences, Inc.'s market cap?

Arcadia Biosciences, Inc. (RKDA) has a market capitalization of $1.5M.

What is RKDA's P/E ratio?

A meaningful P/E ratio is not available for RKDA — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is RKDA's price-to-book (P/B) ratio?

RKDA trades at 0.37 times book value per share.

When did Arcadia Biosciences, Inc. last report earnings?

RKDA last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying RKDA stock?

SEC Form 4 filings show no open-market insider buys at Arcadia Biosciences, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Agricultural Inputs

AGRZ

Agroz Inc. Ordinary Shares

$7.6M

SEED

Origin Agritech Limited

$8.6M

BIOX

Bioceres Crop Solutions Corp.

$27.4M

BHST

BioHarvest Sciences Inc. Common Stock

$67.6M

AVD

American Vanguard Corporation

$75.5M

IPI

Intrepid Potash, Inc.

$526M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.